EN DE
Watch ASP Isotopes Inc. Common Stock for free: we tell you when fair value or trend changes.
Data-driven stock valuation

ASP Isotopes Inc. (ASPI) fair value: what the stock is really worth

As of Nov 11, 2026: fair value (intrinsic value) of ASP Isotopes Inc. stock $1.67, price $1.96, that is 14.8% below the price, quality 21 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials US · ISIN US00218A1051

AI ASP Isotopes Inc. logo Thin data Nov 10, 2026

ASP Isotopes Inc.

ASPI · US
Expensive, weak quality

Our calculation puts a fair price 15% below what the stock costs today.

Mixed Growth (revenue YoY +475.5 %/yr in USD)
Mixed vs. peers (3/7)
Insiders bought $61,800 (6M) · sold $4.9M
Fair value $1.67 · Overvalued
Quality 21/100
Negative free cash flow
Narrow moat 14/100
Thin data
⟳ CyclicalEstimate
Watch ASP Isotopes Inc. Common Stock for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$14.05 $0.3200 Fair Value $1.67 Nov 2022 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

48‑month range $0.3200 – $14.05 · fair‑value band $1.25 – $2.09 · the $1.96 price screens above the $1.67 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow ASP Isotopes Inc. Common Stock in your weekly email

Every Wednesday you see whether ASP Isotopes Inc. Common Stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services.

Show moreShow less

The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market.

Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs.

The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes.

It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry.

In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Stock analysis

ASP Isotopes Inc. (ASPI) currently trades at $1.96, while our estimate is $1.67, 15% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $1.25 (bear) to $2.09 (bull), the price of $1.96 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

ASP Isotopes Inc. Common Stock reported revenue of $23.8M in FY2025 versus $22.6M in FY2019, a compound +0.9%/yr. Reported net income was −$175M in FY2025.

Key figures

Market cap $305M Small · P/S ratio 10.2 · EPS (TTM) $−1.49 · Return on equity −90.4% · Return on assets (EBIT) −33.9% (5-year average) · Operating margin −667% · Revenue (TTM) $30.9M · Revenue growth (YoY) +328%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (medium confidence).

What moves the price

The share trades about 78% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at −15%, ASPI screens cheaper than that median.

Fair Value

Bear $1.25 Fair Value $1.67 Bull $2.09
Price $1.96 · Downside -14.8%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 21/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 61
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 63
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director bought shares worth $61,800, on Sep 30, 2026. Over the same period, 6 people sold shares worth $4.9M.

  • SaleHeather KiesslingChief Financial Officer4× since Dec 18, 2025: 148,078 shares, avg. $5.29$783,746Oct 16, 2026
  • SaleRobert AinscowCOO10× since Nov 17, 2025: 221,252 shares, avg. $5.51$1.2MOct 14, 202610b5-1 plan
  • BuyRobert John Andrew RyanDirector2× since Sep 28, 2026: 23,000 shares, avg. $2.69$61,800Sep 30, 2026
  • SalePaul Elliot MannChairman and CEO, Director4× since Nov 17, 2025: 827,203 shares, avg. $6.13$5.1MSep 4, 202610b5-1 plan
  • SaleDonald George AinscowEVP, Gen Counsel, Secretary2× since Jun 30, 2026: 123,678 shares, avg. $5.71$706,107Sep 2, 2026
  • SaleMichael GorleyDirector30,000 shares at $6.27$188,100Jun 30, 2026
  • SaleTodd WiderDirector100,000 shares at $6.19$618,500Jun 30, 2026
  • SaleDuncan MooreDirector11,642 shares at $5.21$60,655Apr 16, 202610b5-1 plan

Plus 4 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 10, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 28/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+475.5%
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−45.3% (2019) → −239.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

ASPI screens overvalued: fair value 15% below the price. Compare with Linde plc →

Compare ASP Isotopes Inc. Common Stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 753 stocks

Beats the industry median on 3/6 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 21 · Bottom 25%
Fair Value upside −14.8% · Above median
Profitability
Return on assets −34.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 327.6% · Top 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 1.49× · Cheaper than median
P/S (12 months) 9.88× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)14 · sector 3
FUTURE (revenue growth)100 · sector 67
PAST (return on equity)0 · sector 25
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)0 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.90 ¥68.03 −3% vs ASPI
Linde plc LIN $526.55 $446.62 −15% vs ASPI
PPG Industries, Inc PPG $124.97 $77.68 −38% vs ASPI
DSM-Firmenich AG DSFIR CHF 98.20 CHF 57.84 −41% vs ASPI
Asian Paints Limited ASIANPAINT ₹2,550 ₹1,479 −42% vs ASPI
The Sherwin-Williams Company SHW $355.76 $152.59 −57% vs ASPI
Givaudan SA GIVN CHF 4,084 CHF 1,629 −60% vs ASPI
EMS-CHEMIE HOLDING AG EMSN CHF 846.00 CHF 284.63 −66% vs ASPI
Ecolab Inc ECL $307.86 $97.18 −68% vs ASPI
Air Products and Chemicals, Inc APD $315.18 $75.33 −76% vs ASPI

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ASP Isotopes Inc. Common Stock: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "ASP Isotopes Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/ASPI

Frequently asked questions

Is ASP Isotopes Inc. (ASPI) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $1.67 versus a price of $1.96, about 15% lower (overvalued).
What is the fair value of ASPI?
Our estimate for ASP Isotopes Inc. is $1.67 (as of Nov 10, 2026), built from audited fundamentals. The current price: $1.96.
What is the quality score of ASPI?
ASP Isotopes Inc. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ASP Isotopes Inc. (ASPI)?
Our calculated price target is the estimate of $1.67 (as of Nov 10, 2026). Cautious scenario $1.25, optimistic scenario $2.09. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the ASP Isotopes Inc. Common Stock stock forecast for 2026?
Our estimate puts fair value at $1.67, about 15% lower versus a price of $1.96 (overvalued). Cautious scenario $1.25, optimistic scenario $2.09. The calculation is refreshed regularly with new filings.
What is the revenue of ASP Isotopes Inc. (ASPI)?
ASP Isotopes Inc. reported trailing-twelve-month revenue of about $30.9M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of ASP Isotopes Inc. (ASPI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ASP Isotopes Inc. it is $1.67 per share (as of Nov 10, 2026), against a price of $1.96.
Is ASP Isotopes Inc. Common Stock stock overvalued or undervalued in 2026?
As of Nov 10, 2026, ASPI trades above its calculated fair value: price $1.96, fair value $1.67, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ASPI?
No. The price is what the market pays today ($1.96); the fair value is what the company's own numbers justify ($1.67). For ASP Isotopes Inc. the two are $0.2900 per share apart. That gap is exactly why we show both numbers side by side.
How much is ASP Isotopes Inc. Common Stock worth?
The market values ASP Isotopes Inc. at about $305M (market capitalisation, as of Nov 10, 2026). Per share that is $1.96; our models calculate a fair value of $1.67 per share.
What do the bullish and bearish scenarios say about ASPI?
Our models span a range for ASP Isotopes Inc.: cautious scenario $1.25, base $1.67, optimistic $2.09 per share (as of Nov 10, 2026, price $1.96). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of ASP Isotopes Inc. (ASPI)?
Balance-sheet figures for ASP Isotopes Inc. (as of Nov 10, 2026): return on equity −90.4%. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is ASPI from its 52-week high?
ASP Isotopes Inc. trades at $1.96, about 78% below its 52-week high of $8.87 and 14% above the low of $1.72 (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of $1.67 is for.
Which stocks are comparable to ASP Isotopes Inc. Common Stock?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ASP Isotopes Inc. Common Stock stock attractive at the current price?
The data as of Nov 10, 2026: price $1.96, calculated fair value $1.67 (−15%), Quality Score 21/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. ASP Isotopes Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ASP Isotopes Inc. (ASPI)?
The closing price on Nov 11, 2026 was $1.96. Our estimate is $1.67, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ASP Isotopes Inc. Common Stock right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of ASP Isotopes Inc.

How large is the market capitalisation of ASP Isotopes Inc. (ASPI)?
The market capitalisation of ASP Isotopes Inc. is $305M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ASP Isotopes Inc. (ASPI)?
The price-to-sales ratio of ASP Isotopes Inc. is 10.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of ASP Isotopes Inc. (ASPI)?
Earnings per share at ASP Isotopes Inc. are $−1.49. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of ASP Isotopes Inc. (ASPI)?
The return on equity (ROE) of ASP Isotopes Inc. is −90.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ASP Isotopes Inc. (ASPI)?
On an EBIT basis the return on assets of ASP Isotopes Inc. is −33.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ASP Isotopes Inc. (ASPI)?
The operating margin of ASP Isotopes Inc. is −667% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ASP Isotopes Inc. (ASPI)?
Revenue at ASP Isotopes Inc. is growing +328% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does ASP Isotopes Inc. (ASPI) generate?
The free cash flow of ASP Isotopes Inc. is −$47.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does ASP Isotopes Inc. (ASPI) hold?
ASP Isotopes Inc. holds more cash than debt, $69.6M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch ASP Isotopes Inc. Common Stock in the live analysis

One click puts ASP Isotopes Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.